Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

GFB 111

Known as: GFB-111, GFB111 
 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Cyclic Peptides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Development and Evaluation of Multifunctional Poly(Lactic-co-glycolic acid) Nanoparticles Embedded in Carboxymethyl β-Glucan Porous Microcapsules as a Novel Drug Delivery System for Gefitinib
In this study, a new kind of folic acid (FA)-conjugated and chitosan (CS)-coated poloxamer 407 (P407)/poly(lactic-co-glycolic… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
2016
2016
An evaluation on the implementation of the Employment Equity Act within Spoornet GFB
 
2015
2015
Mitteilungen des Berufsverbandes der Deutschen Radiologen
mögen, so stellt man sich als Selbstverwaltungskörperschaft der Ärzte zur Disposition. Schon werden wieder die Stimmen laut, die… Expand
2011
2011
Production Practice of the Card A186F with the Stationary Wire Flat GFB-IIIQ
In order to upgrade the performance of the conventional card for better configuration,considering the situation that most of the… Expand
2002
2002
MKG-Mitteilungen Januar 2003
  • Mund-, Kiefer- und Gesichtschirurgie
  • 2002
    • Corpus ID: 46421807
– wir sind erstmals in die Verbandsliste des Bundestags aufgenommen – den Ergebnissen der Mitgliederbefragung folgend wird… Expand
Highly Cited
2000
Highly Cited
2000
Design of GFB-111, a platelet-derived growth factor binding molecule with antiangiogenic and anticancer activity against human tumors in mice
We have designed a molecule, GFB-111, that binds to platelet-derived growth factor (PDGF), prevents it from binding to its… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Review
2000
Review
2000
Design of growth factor antagonists with antiangiogenic and antitumor properties
This review describes our recent efforts in the development of novel therapies for cancer. Our primary approach is to design… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 6
2000
2000
A small-molecule PDGF inhibitor
  • J. Jamison
  • Nature Biotechnology
  • 2000
    • Corpus ID: 20087540
promising area involves the design of smallmolecule inhibitors of growth factors active in malignancies. PDGF and its receptors… Expand
2000
2000
Technical Reports
promising area involves the design of smallmolecule inhibitors of growth factors active in malignancies. PDGF and its receptors… Expand
1971
1971
First results of a study with the gastrocamera GFB
 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE